Healthcare provider profile · identity verified

Brian Sanchez, MD

Family Practice · ROCK HILL, SC · NPI 1548757685

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	346	115
Amlodipine Besylate	Amlodipine Besylate	267	88
Lisinopril	Lisinopril	261	93
Omeprazole	Omeprazole	236	73
Levothyroxine Sodium	Levothyroxine Sodium	230	75
Furosemide	Furosemide	160	47
Metformin Hcl	Metformin Hcl	154	56
Metoprolol Succinate	Metoprolol Succinate	154	63
Rosuvastatin Calcium	Rosuvastatin Calcium	151	56
Hydrochlorothiazide	Hydrochlorothiazide	143	51
Gabapentin	Gabapentin	141	51
Losartan Potassium	Losartan Potassium	129	49
Albuterol Sulfate Hfa	Albuterol Sulfate	117	42
Simvastatin	Simvastatin	101	40
Metoprolol Tartrate	Metoprolol Tartrate	98	32
Tramadol Hcl	Tramadol Hcl	94	17
Trulicity	Dulaglutide	85	15
Pantoprazole Sodium	Pantoprazole Sodium	83	32
Jardiance	Empagliflozin	81	20
Tamsulosin Hcl	Tamsulosin Hcl	79	31
Metformin Hcl Er	Metformin Hcl	71	18
Duloxetine Hcl	Duloxetine Hcl	66	31
Montelukast Sodium	Montelukast Sodium	65	18
Meloxicam	Meloxicam	64	25
Ezetimibe	Ezetimibe	62	19
Sertraline Hcl	Sertraline Hcl	62	19
Eliquis	Apixaban	60	22
Tizanidine Hcl	Tizanidine Hcl	58	37
Fluticasone Propionate	Fluticasone Propionate	57	32
Ozempic	Semaglutide	54	13
Carvedilol	Carvedilol	53	22
Trazodone Hcl	Trazodone Hcl	53	16
Naproxen	Naproxen	48	12
Allopurinol	Allopurinol	47	17
Bupropion Xl	Bupropion Hcl	47	11
Baclofen	Baclofen	46	21
Glipizide	Glipizide	46	11
Donepezil Hcl	Donepezil Hcl	45	11
Glimepiride	Glimepiride	45	16
Potassium Chloride	Potassium Chloride	45	15
Clopidogrel	Clopidogrel Bisulfate	43	14
Fluoxetine Hcl	Fluoxetine Hcl	43	11
Famotidine	Famotidine	42	21
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	41	14
Pravastatin Sodium	Pravastatin Sodium	41	15
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	38	suppressed
Bumetanide	Bumetanide	37	12
Citalopram Hbr	Citalopram Hydrobromide	37	15
Lorazepam	Lorazepam	36	suppressed
Spironolactone	Spironolactone	36	13
Celecoxib	Celecoxib	35	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	34	13
Atenolol	Atenolol	33	12
Hydralazine Hcl	Hydralazine Hcl	32	suppressed
Topiramate	Topiramate	32	suppressed
Spiriva Respimat	Tiotropium Bromide	31	suppressed
Alprazolam	Alprazolam	30	suppressed
Ventolin Hfa	Albuterol Sulfate	30	suppressed
Azithromycin	Azithromycin	29	29
Nystatin	Nystatin	29	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	29	suppressed
Prednisone	Prednisone	29	25
Clonidine Hcl	Clonidine Hcl	28	suppressed
Entresto	Sacubitril/Valsartan	28	suppressed
Januvia	Sitagliptin Phosphate	28	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	26	25
Fenofibrate	Fenofibrate	26	suppressed
Pregabalin	Pregabalin	26	suppressed
Propranolol Hcl Er	Propranolol Hcl	26	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	25	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	25	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	25	20
Synthroid	Levothyroxine Sodium	25	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	22	12
Aripiprazole	Aripiprazole	21	suppressed
Buspirone Hcl	Buspirone Hcl	20	11
Farxiga	Dapagliflozin Propanediol	20	suppressed
Fluconazole	Fluconazole	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Methylprednisolone	Methylprednisolone	20	20
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	suppressed
Alendronate Sodium	Alendronate Sodium	18	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	18	suppressed
Benazepril Hcl	Benazepril Hcl	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	11
Risperidone	Risperidone	18	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Irbesartan	Irbesartan	17	suppressed
Methocarbamol	Methocarbamol	16	suppressed
Sucralfate	Sucralfate	16	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Fenofibrate	Fenofibrate,micronized	15	suppressed
Mirtazapine	Mirtazapine	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Digoxin	Digoxin	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	12
Lamotrigine	Lamotrigine	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Pentoxifylline	Pentoxifylline	13	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Diazepam	Diazepam	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Tradjenta	Linagliptin	12	suppressed
Valsartan	Valsartan	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed
Telmisartan	Telmisartan	11	suppressed
Wegovy	Semaglutide	11	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error